Target Identification in Lupus and Novel Research Grants

Target Identification in Lupus (TIL):  

Supports highly meritorious research focused on the identification and scientific and/or clinical advancement of therapeutic targets that will lead to new therapies for lupus.

Novel Research Grants (NRG): 
Provides early stage support for highly innovative approaches to major challenges in lupus research. Special emphasis is placed on lupus studies exploring fundamental mechanisms, novel targets and pathways, novel technologies, and interdisciplinary approaches.

Funding: $200,000 per year (TIL); $100,000 per year (NRG)
Duration: 3 years

Research authority due date: 2.2.18